PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
35050407-11	2022	During the follow-up, the severity of TR improved in the TLV group (trivial-mild: 52.6%; moderate: 36.8%; severe: 10.5%) (p < 0.01).	Tolvaptan	57-60	coagulation factor II thrombin receptor	Homo sapiens	38-40